Chit Chat Stocks

Chit Chat Stocks
undefined
May 13, 2026 • 1h 10min

(ABNB, ADYEN, WISE, & more) Ranking Ryan's Entire Portfolio

They rank every holding by business quality and valuation and explain the randomization and grading method. Discussions cover remittance rails and margins, Adobe’s AI risk and buybacks, Alphabet’s full-stack AI edge, Wise’s low-cost banking approach, Airbnb’s supply exclusivity, airport toll-road economics, TSMC’s chip moat, and payments integration at Adyen.
undefined
May 8, 2026 • 1h 5min

Palantir, Coupang, and Remitly Earnings; Ryan Cohen's Strange Interview; An Incoming AI IPO $PLTR $RELY $CPNG

Discussion jumps from Palantir's blowout quarter and rapid margin moves to Remitly's strong customer growth and buybacks. Coupang's mixed results and a data-leak subscriber boycott get unpacked. Conversation touches on AI IPO activity, a potential SpaceX offering reshaping liquidity, and a wafer-scale semiconductor IPO buzz.
undefined
May 6, 2026 • 50min

SpaceX, Rocket Lab, And The Future of Defense and Space Stocks With Industry Expert Lou Whiteman

Lou Whiteman, longtime Motley Fool analyst focused on defense tech and commercial space, joins to unpack the sector. He breaks down SpaceX’s business lines and Starlink’s market questions. Lou compares launch players and explains why Rocket Lab’s integrated approach stands out. He highlights government spending, investable subsectors like launch and observation, and timing risks for defense stocks.
undefined
13 snips
May 1, 2026 • 1h 4min

AI Earnings Blitz (GOOG, AMZN, META); South Korean Stock Bonanza; Is Apple's Mojo Back? $AAPL

A rapid rundown of AI-fueled big tech earnings, including cloud backlogs and chip bets driving growth. Deep dives into Apple's revenue momentum and valuation questions. Coverage of memory chip strength in South Korea and a possible cyclical boom. Notes on retail and restaurant resilience, payments durability, and a surprising merger in real estate tech.
undefined
Apr 29, 2026 • 53min

Howard Marks: The Distressed Debt King (What Does He Think About AI and Private Credit?)

A deep dive into distressed-debt investing, from bond math and yield mechanics to real-world crisis plays. Stories include loan-to-equity conversions, airline lending during COVID, and ships-for-equity turnarounds. They debate AI’s limits in investment judgment and warn about private credit’s crowded market.
undefined
Apr 24, 2026 • 1h 4min

Earnings Digest (TSLA, INTC, AXP, PM); Tim Cook's Farewell; Avis Goes Full GameStop $CAR; Playing a Potential SpaceX/Tesla Merger?

They break down recent earnings from Tesla, Intel, American Express and Philip Morris. They debate Tim Cook's legacy and Apple's services shift. They dive into software valuation, AI-driven margin pressures, and semiconductor foundry dynamics. They cover a wild meme squeeze at Avis and speculate on a possible SpaceX/Tesla merger and related market plays.
undefined
Apr 22, 2026 • 1h 2min

Is Wix Stock Too Cheap To Ignore? (Ticker: WIX)

Manuel Cunha, founder of MVC Investing and SaaS analyst, breaks down why Wix plunged and whether it is mispriced. He covers capital moves like the Dutch auction buyback and private placement, Wix Harmony and Base44 growth, AI risks and customer stickiness, plus valuation and scenarios that could trigger a re-rating.
undefined
11 snips
Apr 17, 2026 • 1h 6min

Earnings Kickoff (TSM, ASML, NFLX); AI Absurdities; Amazon's Starlink Competitor; Hermes Opportunity

They kick off earnings season with lively takes on TSMC and ASML results and valuation tradeoffs. A wild Allbirds-to-AI meme stock pop gets unpacked. Luxury name Hermès’ big drawdown and Coupang’s AI bets spark debate. Netflix’s growth, ad strategy and live events are covered. Amazon’s satellite move against Starlink and shifts in AI model market share round out the conversation.
undefined
Apr 15, 2026 • 54min

Huge Opportunity (HIMS) In The Peptide Market? Why Hims & Hers Stock May Benefit + Healthcare Industry Implications

Travis Hoium, founder of Asymmetric Investing and former Motley Fool writer, explores the rise of peptides and their potential to reshape healthcare. He discusses GLP-1 economics, regulatory and safety questions, which industries could be disrupted, and how a consumer-focused healthcare company might capitalize through personalized care and data-driven services.
undefined
Apr 10, 2026 • 1h 6min

Amazon’s Annual Letter Insights; New Insider Buys; Claude’s Record Setting ARR Growth

They unpack Claude’s staggering ARR jump and what it means for AI platforms. They dive into Amazon’s annual letter, focusing on cloud, custom chips, and same-day commerce wins. They discuss insider buys, insurance sector moves, and a list of the worst S&P performers. They also debate consulting’s fate in an AI world and examine small-cap ideas like a Latin American gym chain.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app